Literature DB >> 8405325

Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille.

C Vignoli, C Zandotti, X De Lamballerie, C Tamalet, J A Gastaut, P De Micco.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8405325     DOI： 10.1007/bf00146277

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  8 in total

1.  Seroprevalence of HTLV-I and HTLV-II.

Authors:  A R Zanetti; C Galli
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

2.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

3.  [Coexistence of HIV-1 and HTLV-1 infections in Marseilles].

Authors:  C Tamalet; S Rousseau; C Benaim; H Gallais; J Tamalet
Journal:  Presse Med       Date:  1989-02-04       Impact factor: 1.228

4.  Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.

Authors:  R F Khabbaz; I M Onorato; R O Cannon; T M Hartley; B Roberts; B Hosein; J E Kaplan
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

Authors:  M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; W C Greene
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

6.  HTLV-I and HIV infection in drug addicts in Italy.

Authors:  A Gradilone; M Zani; G Barillari; M Modesti; A M Agliano; G Maiorano; L Ortona; L Frati; V Manzari
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

7.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

8.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

Authors:  G D Ehrlich; J B Glaser; K LaVigne; D Quan; D Mildvan; J J Sninsky; S Kwok; L Papsidero; B J Poiesz
Journal:  Blood       Date:  1989-10       Impact factor: 22.113
  8 in total
  3 in total

Review 1.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France.

Authors:  C Vignoli; X De Lamballerie; C Zandotti; R De Chesse; C Tamalet; P De Micco
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.